Q2 2024 · 13F-HR
Ikarian Capital, LLCholdings as filed
Filed 2024-08-14 · accession 0001420506-24-001556
$574.1M
Reported value
113
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $36.5M | 6.35% | 1,500 | CALL | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $36.5M | 6.35% | 1,500 | PUT | SOLE |
| 457669307 | INSM | INSMED INC | $34.0M | 5.92% | 5,070 | CALL | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $32.2M | 5.60% | 203,612 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $26.4M | 4.59% | 588,818 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $21.8M | 3.79% | 800,277 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $18.7M | 3.27% | 600 | CALL | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $18.2M | 3.17% | 445,451 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $17.5M | 3.04% | 4,225 | PUT | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $15.8M | 2.75% | 1,000 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $15.2M | 2.65% | 6,000 | CALL | SOLE |
| 21833P301 | CRBP | CORBUS PHARMACEUTICALS HLDGS | $14.0M | 2.44% | 309,540 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $13.8M | 2.40% | 1,000 | CALL | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $13.7M | 2.39% | 586,552 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $12.4M | 2.16% | 3,000 | CALL | SOLE |
| 031162100 | AMGN | AMGEN INC | $12.0M | 2.08% | 38,300 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $11.5M | 2.00% | 151,601 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $9.2M | 1.61% | 170,147 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $9.2M | 1.60% | 440,500 | Common | SOLE |
| 015271109 | ARE | ALEXANDRIA REAL ESTATE EQ IN | $8.6M | 1.49% | 733 | PUT | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $8.5M | 1.48% | 1,092 | CALL | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $8.4M | 1.46% | 332,013 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $8.0M | 1.40% | 518,386 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $7.3M | 1.28% | 138,262 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $7.3M | 1.27% | 276,925 | Common | SOLE |
| 816212302 | RNAC | CARTESIAN THERAPEUTICS INC | $6.5M | 1.14% | 242,370 | Common | SOLE |
| 00445A100 | — | ACELYRIN INC | $6.5M | 1.13% | 1,475,074 | Common | SOLE |
| 218352102 | CORT | CORCEPT THERAPEUTICS INC | $6.0M | 1.05% | 1,860 | CALL | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $5.5M | 0.96% | 40,000 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $5.5M | 0.96% | 1,662,408 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $4.8M | 0.83% | 709 | PUT | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $4.6M | 0.79% | 489,642 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $4.2M | 0.74% | 197,096 | Common | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $4.2M | 0.73% | 107,187 | Common | SOLE |
| 15713L109 | CRVO | CERVOMED INC | $4.1M | 0.71% | 237,345 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $3.9M | 0.68% | 903,744 | Common | SOLE |
| 23256X100 | — | CYBIN INC | $3.8M | 0.66% | 13,953,488 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $3.6M | 0.63% | 2,789 | PUT | SOLE |
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $3.5M | 0.62% | 204,513 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $3.3M | 0.57% | 506,665 | Common | SOLE |
| 45720N103 | INBX | INHIBRX BIOSCIENCES INC | $3.3M | 0.57% | 230,000 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $3.3M | 0.57% | 768,593 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $3.2M | 0.56% | 47,835 | Common | SOLE |
| 03615A108 | ANVS | ANNOVIS BIO INC | $3.2M | 0.55% | 5,517 | PUT | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $3.1M | 0.54% | 458,497 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $2.9M | 0.51% | 12,864 | PUT | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $2.9M | 0.51% | 201,116 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $2.9M | 0.50% | 575,088 | Common | SOLE |
| 3621LQ109 | GTHXEUR | G1 THERAPEUTICS INC | $2.8M | 0.49% | 12,248 | CALL | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.6M | 0.46% | 1,000 | CALL | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $2.4M | 0.42% | 105,175 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $2.3M | 0.41% | 323,528 | Common | SOLE |
| 03969F109 | RCUS | ARCUS BIOSCIENCES INC | $2.2M | 0.38% | 145,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $2.2M | 0.38% | 4,000 | CALL | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $2.2M | 0.38% | 4,000 | PUT | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $2.0M | 0.34% | 109,094 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $1.9M | 0.32% | 690,089 | Common | SOLE |
| 03589W102 | ANNX | ANNEXON INC | $1.9M | 0.32% | 380,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $1.8M | 0.32% | 302,908 | Common | SOLE |
| 640268108 | NKTREUR | NEKTAR THERAPEUTICS | $1.6M | 0.28% | 1,312,405 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.5M | 0.27% | 183,701 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $1.4M | 0.25% | 412,565 | Common | SOLE |
| 89157D105 | TRML | TOURMALINE BIO INC | $1.4M | 0.24% | 108,483 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.3M | 0.23% | 1,000 | CALL | SOLE |
| 451033708 | IBIO | IBIO INC | $1.3M | 0.22% | 600,000 | Common | SOLE |
| N44821101 | IFRX | INFLARX NV | $1.2M | 0.21% | 704,987 | Common | SOLE |
| 747324101 | PYXS | PYXIS ONCOLOGY INC | $1.2M | 0.21% | 3,586 | CALL | SOLE |
| 00449L102 | 698 | ACHILLES THERAPEUTICS PLC | $1.2M | 0.20% | 1,443,181 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $1.2M | 0.20% | 162,481 | Common | SOLE |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $1.2M | 0.20% | 78,574 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.1M | 0.20% | 290 | PUT | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.1M | 0.20% | 290 | CALL | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $1.1M | 0.20% | 476,586 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $1.1M | 0.19% | 100,609 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $1.0M | 0.18% | 358,282 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $1.0M | 0.18% | 62,836 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $1.0M | 0.18% | 442,647 | Common | SOLE |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $972,675 | 0.17% | 972,675 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $850,337 | 0.15% | 200,079 | Common | SOLE |
| 24661P807 | DCTH | DELCATH SYS INC | $840,097 | 0.15% | 100,370 | Common | SOLE |
| 56854Q200 | MRNS* | MARINUS PHARMACEUTICALS INC | $826,200 | 0.14% | 706,154 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $802,748 | 0.14% | 483,583 | Common | SOLE |
| 92536C103 | VERUEUR | VERU INC | $796,191 | 0.14% | 946,382 | Common | SOLE |
| 55083R104 | — | LYELL IMMUNOPHARMA INC | $762,796 | 0.13% | 526,066 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $711,001 | 0.12% | 100,000 | Common | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $682,483 | 0.12% | 54,730 | Common | SOLE |
| 00509G209 | ABOS | ACUMEN PHARMACEUTICALS INC | $644,774 | 0.11% | 266,435 | Common | SOLE |
| 59935V107 | MIST | MILESTONE PHARMACEUTICALS IN | $619,806 | 0.11% | 466,019 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $610,822 | 0.11% | 367,965 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $610,000 | 0.11% | 2,000 | CALL | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $574,202 | 0.10% | 49,415 | Common | SOLE |
| 4525EP101 | VTLUSD | IMMUNIC INC | $547,781 | 0.10% | 493,496 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $521,647 | 0.09% | 274,551 | Common | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $521,395 | 0.09% | 868,992 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $471,606 | 0.08% | 154,625 | Common | SOLE |
| 92915B106 | VYGR | VOYAGER THERAPEUTICS INC | $441,829 | 0.08% | 55,857 | Common | SOLE |
| 034569103 | ANEB | ANEBULO PHARMACEUTICALS INC | $430,964 | 0.08% | 157,862 | Common | SOLE |
| 81728A108 | SNSEEUR | SENSEI BIOTHERAPEUTICS INC | $403,065 | 0.07% | 650,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $375,881 | 0.07% | 180,712 | Common | SOLE |
| B6S7WD106 | NYXH | NYXOAH S A | $356,921 | 0.06% | 50,699 | Common | SOLE |
| 48576U106 | KPTIEUR | KARYOPHARM THERAPEUTICS INC | $355,157 | 0.06% | 409,355 | Common | SOLE |
| 03615A108 | ANVS | ANNOVIS BIO INC | $297,792 | 0.05% | 517 | CALL | SOLE |
| 55234L105 | LYRAGBP | LYRA THERAPEUTICS INC | $292,424 | 0.05% | 1,056,829 | Common | SOLE |
| 00791X100 | — | AEON BIOPHARMA INC | $270,876 | 0.05% | 257,977 | Common | SOLE |
| 87978U108 | OVASUSD | TEMPEST THERAPEUTICS INC | $231,264 | 0.04% | 105,600 | Common | SOLE |
| 16385C104 | — | CHEMOMAB THERAPEUTICS LTD | $196,320 | 0.03% | 213,392 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $166,000 | 0.03% | 1,000 | CALL | SOLE |
| 75955J402 | RLMD | RELMADA THERAPEUTICS INC | $121,107 | 0.02% | 40,369 | Common | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $92,083 | 0.02% | 6,816 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $72,504 | 0.01% | 171 | CALL | SOLE |
| 87166L209 | SYBX | SYNLOGIC INC | $30,673 | 0.01% | 20,448 | Common | SOLE |
| 10501E201 | BCLIEUR | BRAINSTORM CELL THERAPEUTICS | $30,547 | 0.01% | 90,242 | Common | SOLE |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $10,887 | 0.00% | 8,924 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.